Gómez, Oscar http://orcid.org/0000-0001-5987-013X
Campusano, Claudia http://orcid.org/0000-0001-5483-9301
Cerdas-P, Sonia http://orcid.org/0000-0003-2530-4169
Mendoza, Beatriz http://orcid.org/0000-0002-7898-9336
Páez-Talero, Amanda
de la Peña-Rodríguez, María Pilar http://orcid.org/0000-0002-2581-134X
Reza-Albarrán, Alfredo Adolfo http://orcid.org/0000-0002-3732-8726
Rueda-Plata, Pedro Nel http://orcid.org/0000-0001-8576-3645
Funding for this research was provided by:
FAES FARMA S.A.
Pontifical Xavierian University
Article History
Received: 4 December 2023
Accepted: 1 May 2024
First Online: 8 June 2024
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: OG attended academic events with the support of GSK and Roche and consults for Pharmalab. CC received support for an academic event and has received lecture fees from Tecnofarma and was previously employed as Medical Director at Clínica Universidad de Los Andes. SC has received support from MD Pharma, Janssen Cilag, Asofarma and Pfizer and has been a speaker for Asofarma and MD Pharma. BM received support for attending academic events from Gador and research grants from Urufarma. APT assisted to academic events with the support of Amgen and Novo Nordisk and has received lecture fees from MSD. MPDP has been a speaker in academic events for Lilly and Amgen and received research grants from Lilly. AARA assisted to an academic event with the support of Merck. PNR has received support from Lilly for an academic event and has been a speaker for Lilly and Sanulac. All authors declare that there were no specific conflicts of interest during the development of this project, and that the content of the Clinical Practice Guidelines was generated in accordance with the pre-specified methodology.